Cart
sales@molnova.com
SSAA09E2
CAS No. 883944-52-3
SSAA09E2( —— )
Catalog No. M24901 CAS No. 883944-52-3
SSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 69 | In Stock |
|
| 5MG | 110 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 410 | In Stock |
|
| 50MG | 605 | In Stock |
|
| 100MG | 860 | In Stock |
|
| 500MG | 1728 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSSAA09E2
-
NoteResearch use only, not for human use.
-
Brief DescriptionSSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
-
DescriptionSSAA09E2 is a new SARS-CoV replication inhibitor, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorHuman ACE2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number883944-52-3
-
Formula Weight300.36
-
Molecular FormulaC16H20N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:230 mg/mL?(765.75 mM;?Need ultrasonic)
-
SMILESO=C(C1=CC=NO1)NCC2=CC=C(N3CCN(C)CC3)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.?Bibi N, et al. Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19. Eur J Pharmacol. 2020;885:173496.
molnova catalog
related products
-
Buloxibutid
Buloxibutid (AT2 receptor agonist C21) is a novel and selective small molecule angiotensin II AT2 receptor agonist, exhibiting Ki values of 0.4 nM and 10 μM for AT2 and AT1 receptors, respectively.
-
(-)-3,5-Dicaffeoyl q...
3,5-Dicaffeoylquinic acid is an isolated compound from Artemisia argyi; its ester derivatives exert anti-leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects.
-
FPL-62129
FPL-62129 is a calcium channel antagonist and a novel angiotensin-converting enzyme inhibitor with vasodilator activity for the study of cardiovascular disease.
